FDA Approves New Animal Drug Gamithromycin for Bovine Respiratory Disease

Summary

The US Food and Drug Administration (FDA) has amended its animal drug regulations to approve the use of gamithromycin injectable solution for treating bovine respiratory disease (BRD) in cattle, following a submission by Merial, Ltd. The approval also establishes tolerances for residues of gamithromycin in edible cattle tissues.